Maintaining the minimal: dynamics of measurable residual disease with continuous lenalidomide therapy

Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Susan Bal, Luciano J Costa
Source: The Lancet Haematology - Category: Hematology Source Type: research
More News: Hematology | Revlimid